CARLSBAD, Calif., Dec. 7 /PRNewswire-FirstCall/ -- Genoptix, Inc. , a specialized laboratory services provider, today announced the Company's participation at the Deutsche Bank 2009 MedTools Investor Conference to be held at the Intercontinental Hotel in Boston, Mass. on December 9-10, 2009.
About Genoptix, Inc.
Genoptix is a leading specialized laboratory service provider focused on delivering personalized and comprehensive diagnostic services to its physician customers, community-based hematologists and oncologists. On the forefront of personalized diagnostic services, Genoptix's highly trained group of hematopathologists utilize sophisticated technology to provide integrated testing and actionable diagnostic reports. Its diagnostic services are designed to optimize the care of patients suffering from hematomalignancies, or cancers of the blood and bone marrow, including leukemia and lymphoma. Founded in 1999, Genoptix completed its initial public offering in November 2007 and is headquartered in Carlsbad, California. For more information, please visit www.genoptix.com.
CONTACT: Marcy Graham, Sr. Director, Investor Relations of Genoptix, Inc.,
+1-760-930-7150, investorrelations@genoptix.com; or Sarah Thailing,
Principal of Wordanista, +1-619-994-1895, sarah@wordanista.com, for
Genoptix, Inc.
Web site: http://www.genoptix.com/
